Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-15

Clinical Trial Update: A Clinical Trial of Parkinson's Disease Treatment by HiPSCs Derived Dopaminergic Neural Precursor Cells [NA]

View source ↗

Summary

A recruiting clinical trial is evaluating a cell therapy made from human induced pluripotent stem cell–derived dopaminergic neural precursor cells for Parkinson…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HiPSCs-derived dopaminergic neural precursor cells

Snippet

Sponsor: Shanghai East Hospital | Conditions: Parkinson's Disease | NA | Status: RECRUITING